Association of Rubella, Cytomegalovirus, and Toxoplasma Infections with Recurrent Miscarriages in Bonab-Iran: A Case-Control Study

authors:

avatar Hesam Nasirpour 1 , * , avatar Yashar Azari Key 2 , avatar Nasrin Kazemipur 3 , avatar Mehdi Majidpour 1 , avatar Saman Mahdavi 4 , avatar Saba Hajazimian 5 , avatar Alireza Issazadeh 5 , avatar Sina Taefehshokr 2

Department of Clinical Sciences, Faculty of Veterinary Medicine, Islamic Azad University, Tabriz Branch, Tabriz, Iran
Young Researchers and Elite Club, Tabriz Branch, Islamic Azad University, Tabriz, Iran
Department of Physiology, Science and Research Branch, Islamic Azad University, Tehran, Iran
Young Researchers Club and Elite, Maragheh Branch, Islamic Azad University, Maragheh, Iran
Department of Genetics, Tabriz Branch, Islamic Azad University, Tabriz, Iran

how to cite: Nasirpour H, Azari Key Y, Kazemipur N, Majidpour M, Mahdavi S, et al. Association of Rubella, Cytomegalovirus, and Toxoplasma Infections with Recurrent Miscarriages in Bonab-Iran: A Case-Control Study. Gene Cell Tissue. 2017;4(3):e60891. https://doi.org/10.5812/gct.60891.

Abstract

Background:

Recurrent miscarriage is defined as a condition with two or more consecutive abortions before the 20 weeks of gestation. Recurrent miscarriage is a multi-factorial disease, which occurs in approximately 1% - 2% of women at the reproductive age. Congenital infection is one of the most important factors in the recurrent miscarriages.

Objectives:

The aim of this study was to investigate the effects of rubella, cytomegalovirus, and toxoplasma infections on recurrent miscarriage in Bonab county.

Methods:

This is a case-control study. Blood samples from a total of 100 women with recurrent miscarriage and 100 healthy women aged 20 to 35 years were taken and serum were separated. Antibodies against Rubella, Cytomegalovirus, and Toxoplasma were read by direct enzyme-linked immunosorbent assay (ELISA). Finally, data were statistically analyzed.

Results:

A total of 31 patients and 14 controls were positive for IgG antibodies against Toxoplasma. In addition, 27 persons in the patient group and 11 in the control group were positive for the presence of IgG antibodies against Cytomegalovirus. A total of 29 patients and 11 controls were positive for IgG antibodies against Rubella.

Conclusion:

In this study, there was a significant difference in the prevalence of anti-Rubella, Cytomegalovirus, and Toxoplasma antibodies between women with recurrent miscarriage and healthy women.

1. Background

Recurrent miscarriage refers to the incidence of 3 abortions or more before the first half of pregnancy. The causes of this disease are multifactorial that can be attributed to factors such as infectious, immunological, hormonal, chromosomal, anatomical, and coagulation factors (1-4). About 5% of all Recurrent Miscarriages are infectious (5, 6). Congenital infections are the most important threats to the health of the fetus in humans, most of which are caused by viral agents. Viruses are among the most contagious infectious agents and the mother's infection before or during pregnancy is one of the factors causing the fetus to be at high risk of infection. Viruses can cause abortion, intrauterine growth retardation, stillbirth, the death of a premature infant, and congenital anomalies (7, 8).

The Rubella virus is a resilient virus that can exert teratogenic effects on the human embryo. Symptoms of the disease include neurological disorders (temporary meningoencephalitis, hypotonia, mental disability), visual disorders (cataract, glaucoma, and retinitis), hearing disorders (bilateral hearing loss), and cardiovascular disorders. The virus has the ability to transfer from placenta to fetus, and the risk of infecting the fetus depends on the age of the fetus when the mother is infected. The risk of abnormalities in the fetus in the first 12 weeks of pregnancy is 85% and after 16 weeks, it reaches the lowest point (9, 10).

Cytomegalovirus is a virus with a double-stranded DNA genome from the Herpes virus family. Its prevalence is intrauterine, followed by shedding of primary infection from the body for months or even years that can be contagious. It usually has a latency period and can be reactivated and cause illness. If the mother is infected with the primary infection, the fetus in 40-50% of cases is infected, too. If mother is infected with a recurrent infection, the risk of infection in the fetus is 1%, leading to jaundice, mental disability, hearing loss, and ultimately abortion (11, 12).

The causative agent of toxoplasmosis is a compulsory intracellular protozoan named Toxoplasma gondii. Four classic symptoms of congenital toxoplasmosis are hydrocephalus, chorioretinitis, intracranial calcification, and lymphadenopathy. Lymphadenopathy is the most common symptom. It is caused by the immune deficiency. This parasitic protozoan is transmitted in three forms of oocysts in cat feces, tachyzoites in the acute phase of the disease with high replication rate, and bradyzoites that are intrinsic to the cysts and slowly replicates. A pregnant mother is able to transfer the infection to the fetus throughout the whole pregnancy period. According to various studies, the risk of transmitting the infection in the first few weeks of pregnancy is 20 percent, but the chance to see the morphological abnormalities is 10%, whereas, after 30 weeks of pregnancy, the chance of transmitting infection is 90 percent, but morphological abnormalities actually are not seen (13, 14).

Therefore, considering the importance of Cytomegalovirus, Rubella, and Toxoplasma in the development or exacerbation of abortion conditions, the role of these infections in pregnant women in Bonab County was investigated.

2. Methods

2.1. Study Subjects

This study is a case-control type. The study population included 100 women at the age of 20 to 40 years with a history of at least 3 consecutive abortions. The karyotypes and anatomical structure were normal in all patients, and any other identifiable cause of abortion was not figured out. Therefore, the abortion in all of the subjects was classified as unexplained recurrent miscarriages. In addition, the age-matched control subjects were 100 healthy women with a history of at least 2 successful pregnancies. All of the women were selected from those referring to the Bonab county medical diagnostic laboratory and informed consent forms were completed by them over a 26-month period (May 2013- July 2015).

2.2. ELISA Analysis

All participants in this study were evaluated to determine the etiologic factors of abortion, through conducting infectious, hormonal, and immunological studies. From each individual in control and patient groups, 5cc blood samples were taken and their serum were stored at -20°C until serologic tests for detecting antibodies. Identification of IgG and IgM antibodies against Toxoplasma, Rubella, and Cytomegalovirus was performed directly according to the instructions of specific ELISA kits (Euromium, Germany) by an ELISA reader (ELISA reader Lab System Multi Scan) (Italy) at a wavelength of 490 nm due to light absorption.

2.3. Statistical Analysis

Seroprevalence of antibodies against Toxoplasma, Cytomegalovirus, and Rubella infection was statistically analyzed in patients with recurrent miscarriages (case group) and healthy women (control group). For this purpose, the results were analyzed by SPSS version 23. They were expressed as mean and standard deviation for quantitative variables and number and percentage for qualitative values. P < 0.05 was considered statistically significant.

3. Results

In this study, 100 patients with recurrent miscarriage as a case group and 100 patients with a successful pregnancy history as a control group were studied in the range of 20 - 40 years old (Table 1). As shown in Table 2, in the present study, 31 of the patients (31%) and 14 of the control group (14%) were positive for the presence of IgG antibodies against Toxoplasma. The prevalence of anti-Toxoplasma antibodies was significantly higher in the patient group than in the control group (P = 0.003). 27 patients (27%) and 11 (11%) of the control group were positive for IgG antibodies against Cytomegalovirus. The prevalence of antibodies against Cytomegalovirus was significantly higher in the patient group than in the control group (P = 0.0006). Also, 29 patients (29%) and 11 of the control group (11%) were positive for IgG antibody against Rubella (Table 2). In this case, the prevalence of antibodies against Rubella was also significantly higher in the patient group than in the control group (P = 0.0014).

Table 1.

Demographic Information of the Case and Control Groupsa,b

VariablePatient GroupControl GroupP Value
Age, (Year)20 - 2518 cases (18)25 cases (25)0.19
26 - 3043 cases (43)41 cases (41)
31 - 3539 cases (39)34 cases (34)
WeightBMI, kg/m223.76 ± 323.41 ± 30.12
EducationHigh school diploma69 cases (69)73 cases (73)0.1
Higher Education31 cases (31)27 cases (27)
Table 2.

The Frequency of Rubella, cytomegalovirus, and Toxoplasma and Their Association with Recurrent Abortionsa,b

Type of InfectionPatient Group (100)Control Group (100)P ValueOR (95% CI)
Toxoplasma31 (31)14 (14)0.0031.9 (0.99 - 3)
Cytomegalovirus27 (27)11 (11)0.00062.7 (2.91 - 5.11)
Rubella29 (29)11 (11)0.00141.1 (0.61 - 2)

4. Discussion

About 21 to 41% of premature parturitions are due to intrauterine infections (12). The access of microorganisms to the embryo before parturition causes the inflammatory response syndrome of the fetus against producing microbial products leading to premature labor. The consequences are multiple organ dysfunction syndrome (MODS) in the embryo and an increase in the mortality rate of the fetus (9). The results of this study showed that viral and parasitic bodies (Cytomegalovirus, Toxoplasma, and Rubella) are significantly evident and available in the blood serum of women.

Rubella, Cytomegalovirus, and Toxoplasma are known to cause infection in the uterus and are responsible for abortion, stillbirth, premature infant, and congenital anomalies (15). Diagnosis and timely treatment of these infections can prevent the death of infants born from infected mothers (16). Many studies have been done in this regard in Iran. In a case-control study, Ebadi et al. (2011) reported a significant relationship between abortion and infection with Cytomegalovirus (5). In another study conducted on women with fetal loss in Ahwaz (2004), 25.28% had IgG antibodies against Toxoplasma gondii (6).

In a study carried out by Janan et al. (2013) in Rasht, IgM-CMV and IgG-CMV were studied in women with spontaneous abortion. They reported that the high titer of IgM-CMV and IgG-CMV plays the most important role in recurrent pregnancy loss (17). In another study, Ebadi et al. (2011) in Jahrom reported the significant association of prevalence of Rubella with recurrent spontaneous abortion (5). Therefore, our study is compatible with these studies. Non-pregnant women with the healthy immune system in most cases of this disease require no treatment. However, if a pregnant woman is in the acute phase of the disease, she should immediately be treated.

Serological and molecular methods for the detection of Rubella, Cytomegalovirus, and Toxoplasma infection in mother and fetus are two basic pillars and are commonly used in most studies. Wan et al. (1996) showed that ELISA is a suitable method for the diagnosis of congenital Cytomegalovirus infection (18). Typically, IgM antibodies are produced after primary infection, but they also appear after non-primary infections and therefore their identification has no diagnostic value. However, the presence of IgM with the low avidity of IgG is a safe serologic index for primary infection. The study of Dualard et al. (2011) showed that most cases of low IgG avidity were observed in positive IgM cases. The high titer of IgG predicts a low IgM avidity, and these two serological data provide useful clinical information for determining the type of Rubella, Cytomegalovirus, and Toxoplasma infection during pregnancy (19).

Considering that factors such as population density, poor health, and socioeconomic status affect women's immunity to Rubella virus, in different countries, according to the sensitivity of women, vaccination is planned. Comparing these results with studies in other parts of Iran, no significant difference was observed. According to the results obtained in this study, suggestions can be made a follows: accurate serological tests before marriage; accurate serological tests before, during, and after pregnancy; continuous and repeated training for women, especially in villages.

Acknowledgements

References

  • 1.

    Isazadeh A, Hajazimian S, Rahmani SA, Mohammadoo-Khorasani M, Samanmanesh S, Karimkhanilouei S. The effects of Factor II (rs1799963) polymorphism on recurrent pregnancy loss in Iranian Azeri women. Italian J Lab Med. 2017;13(1):37-40. https://doi.org/10.1007/s13631-017-0145-y.

  • 2.

    Isazadeh A, Haj Azimian S, Tariverdi N, Rahmani SA, Esmaeili M, Karimkhanilouei S, et al. Effects of coagulation factor XIII (Val34Leu) polymorphism on recurrent pregnancy loss in Iranian Azeri women. LaboratoriumsMedizin. 2017;41(2). https://doi.org/10.1515/labmed-2017-0012.

  • 3.

    Hajizadeh YS, Emami E, Nottagh M, Amini Z, Maroufi NF, Azimian SH, et al. Effects of interleukin-1 receptor antagonist (IL-1Ra) gene 86 bp VNTR polymorphism on recurrent pregnancy loss: a case-control study. Horm Mol Biol Clin Investig. 2017;30(3). [PubMed ID: 28593919]. https://doi.org/10.1515/hmbci-2017-0010.

  • 4.

    Isazadeh A, Hajazimian S, Rahmani SA, Mohammadoo-Khorasani M, Moghtaran N, Maroufi NF. The effect of factor-xi (rs3756008) polymorphism on recurrent pregnancy loss in Iranian Azeri women. Gene Cell Tissue. 2017;4(1).

  • 5.

    Ebadi P, Yaghobi R, Eftekhar F, Bagheri K. Seroprevalence of CMV and Rubella in women with recurrent spontaneous abortion in comparison with normal delivery. J Fasa Univ Med Sci. 2011;1(3):136-41.

  • 6.

    Hadi-Nodoushan H, MirAhmadian M, Aflatoonian A, Akbari-Asbagh F. The Role of Peripheral Natural Killer Cells in Recurrent Spontaneous Abortions. SSUJ. 2004;12(2):53-9.

  • 7.

    Czeresnia JM, Araujo Junior E, Cordioli E, Martins WP, Nardozza LMM, Moron AF. Applicability of the Rapid Biophysical Profile in Antepartum Fetal Well-Being Assessment in High-Risk Pregnancies from a University Hospital in São Paulo, Brazil: Preliminary Results. ISRN Obstetr Gynecol. 2013;2013.

  • 8.

    Taksande A, Vilhekar K, Chaturvedi P, Jain M. Congenital malformations at birth in Central India: A rural medical college hospital based data. Indian J Hum Genet. 2010;16(3):159-63. [PubMed ID: 21206705]. https://doi.org/10.4103/0971-6866.73412.

  • 9.

    Miyakawa M, Yoshino H, Yoshida LM, Vynnycky E, Motomura H, Tho le H, et al. Seroprevalence of rubella in the cord blood of pregnant women and congenital rubella incidence in Nha Trang, Vietnam. Vaccine. 2014;32(10):1192-8. [PubMed ID: 24021315]. https://doi.org/10.1016/j.vaccine.2013.08.076.

  • 10.

    Kliegman RM, Behrman RE, Jenson HB, Stanton BMD. Nelson Textbook of Pediatrics E-Book. Elsevier Health Sciences; 2007.

  • 11.

    Demmler GJ. Congenital cytomegalovirus infection and disease. Adv Pediatr Infect Dis. 1996;11:135-62. [PubMed ID: 8718462].

  • 12.

    Nigro G, Adler SP, La Torre R, Best AM, Congenital Cytomegalovirus Collaborating G. Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med. 2005;353(13):1350-62. [PubMed ID: 16192480]. https://doi.org/10.1056/NEJMoa043337.

  • 13.

    Unzaga JM, More G, Bacigalupe D, Rambeaud M, Pardini L, Dellarupe A, et al. Toxoplasma gondii and Neospora caninum infections in goat abortions from Argentina. Parasitol Int. 2014;63(6):865-7. [PubMed ID: 25128663]. https://doi.org/10.1016/j.parint.2014.07.009.

  • 14.

    Dubey JP. Review of Neospora caninum and neosporosis in animals. Korean J Parasitol. 2003;41(1):1-16. [PubMed ID: 12666725].

  • 15.

    Ma YY. Effects of cytomegalovirus infection in pregnant women to fetuses: study with DNA-DNA hybridization method. Zhonghua fu chan ke za zhi. 1992;27(6):355-8. 380.

  • 16.

    Liesnard C, Donner C, Brancart F, Gosselin F, Delforge ML, Rodesch F. Prenatal diagnosis of congenital cytomegalovirus infection: prospective study of 237 pregnancies at risk. Obstet Gynecol. 2000;95(6 Pt 1):881-8. [PubMed ID: 10831985].

  • 17.

    Janan A, Honarmand H, Amirmozafari N, Asgharnia M, Janan A. Study on seroprevalence of cytomegalovirus in pregnant women and the association of cytomegalovirus seropositivity to spontaneous abortion. J Mazand Univ Med Sci. 2013;23(105):36-42.

  • 18.

    Wen L, Wu S, Lu S. [The epidemiological study on human cytomegalovirus infection of pregnant women and the maternal-fetal transmission in three Chinese metropolis]. Zhonghua Fu Chan Ke Za Zhi. 1996;31(12):714-7. [PubMed ID: 9387510].

  • 19.

    Revello MG, Gerna G. Diagnosis and Management of Human Cytomegalovirus Infection in the Mother, Fetus, and Newborn Infant. Cli Microbiol Rev. 2002;15(4):680-715. https://doi.org/10.1128/cmr.15.4.680-715.2002.